drugset / Trial / NCT00354809
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
RandomizedCrossoverDouble-blindTreatment
Summary
This study is designed to determine whether morning doses of GW679769, taken daily for 1 to 9 days, will promote sleep during the following night without significant post-dose thinking impairment and drowsiness in subjects with primary insomnia.
Timeline
- Start
- 2006-05
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Casopitant | Small molecule | 10 mg | — |
| Subject | Casopitant | Small molecule | 30 mg | — |